Retatrutide 5mg 10mg farashi mai rahusa

Sunan samfurin: Retatrutide

Musammantawa: 5mg*10vial/kit 10mg*10vials/kit

MOQ: 1 kit

Farashin: 5mg USD320/kit 10mg USD600/kit

Wurin Asalin: China

Retatrutide

Retatrutide (LY-3437943) yana ƙarƙashin haɓaka don kula da nau'in ciwon sukari na 2 na ciwon sukari, bugun barci mai hanawa, osteoarthritis, kiba da cutar hanta mai kitse mara giya.Ana gudanar da dan takarar miyagun ƙwayoyi ta hanyar subcutaneous da kuma ta hanyar jijiya.Dan takarar miyagun ƙwayoyi yana aiki ta hanyar glucagon-kamar peptide 1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), da masu karɓar glucagon.Sabbin kwayoyin halitta ne.

Retatrutide yana aiki a cikin maganin kiba ta hanyar yin niyya daban-daban na sarrafa hormones na yunwa: - GIP (inhibitory peptide na ciki ko insulinotropic polypeptide mai dogaro da glucose) shine hormone incretin wanda ke fitowa daga hanji bayan cin abinci.Retatrutide yana motsa ƙwayoyin beta a cikin pancreas don ɓoye insulin.Magungunan peptide ne tare da jerin amino acid.Yana da agonist mai karɓar hormone sau uku na GLP-1, GIP, da masu karɓar GCGR.An nuna don cimma fiye da kashi 24% na ma'anar rage nauyi a cikin wadanda ba masu ciwon sukari ba ko kuma manya masu kiba.

Retatrutide yayi kama da Ozempic, Wegovy, da Mounjaro a cikin cewa shine allurar hormones sau ɗaya a kowane mako wanda ke canza yadda muke ci, yana haifar da jin daɗi da wuri da raguwar ci.

Amma ba kamar Ozempic da Wegovy ba, waɗanda ke kwaikwayi hormone guda ɗaya kawai na sarrafa yunwa (GLP-1), ko Mounjaro, wanda ke kwaikwayon hormones biyu (GLP-1 da GIP),retatrutidekwayoyin halitta guda daya ne wanda ke kwaikwayi nau'in hormones daban-daban masu sarrafa yunwa: GLP-1, GIP, da glucagon.Wannan mataki na “Triple G”, kamar yadda wasu masana kimiyya suka kira shi a wurin taron, da alama yana da tasiri mai ƙarfi akan sha’awar mutum da gamsuwar abinci.

A cikin gwajin da aka buga a cikin NEJM, marasa lafiya masu kiba waɗanda aka ba su mafi girman kashi na mako-makoretatrutide(12 MG) ya rasa matsakaicin fam 58 a cikin watanni 11.Har yanzu nauyinsu yana raguwa ko da lokacin da gwajin ya ƙare, yana ba da shawarar cewa tsayi, manyan gwaje-gwajen da ba a kammala ba na iya ba da sakamako mai ban sha'awa na asarar nauyi.Kowane majiyyaci a kan mafi girman kashi na retatrutide ya rasa aƙalla 5% na nauyin jikin su, kuma kashi ɗaya cikin huɗu na waɗannan mahalarta sun rasa 30% ko fiye na nauyin su.

A cikin irin wannan binciken na retatrutide ga marasa lafiya masu fama da ciwon sukari na 2 da aka buga a cikin The Lancet, marasa lafiya sun rasa kusan kashi 17% na nauyin jikinsu a cikin watanni tara, wanda shine babban abin al'ajabi, tunda yana da wahala ga marasa lafiya da T2D su rasa adadin nauyin. kamar yadda sauran masu kiba da kiba.

NOTE

Muna jigilar kaya a duk duniya.
Ana ba ku shawarar tuntuɓar shawarwarin likitan ku kafin amfani da samfurin.